PDS Biotech Supports Oral, Head & Neck Cancer Awareness Month During April and Oral, Head & Neck Cancer Awareness Week from April 16-22, 2023

FLORHAM PARK, N.J., April 03, 2023 -- PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious... | April 3, 2023

Related Keywords

United States ,American ,Deanne Randolph ,Amanda Hollinger ,Dave Schemelia ,Kenji Hisamatsu ,Frank Bedu ,Globenewswire Inc ,National Cancer Institute ,Twitter ,Biotechnology Corporation Nasdaq ,Biotechnology Corporation The Company ,Head Neck Cancer Alliance ,Drug Administration ,Neck Cancer Alliance ,American Society For Clinical Oncology ,Merck Co Inc ,United States Securities Exchange ,Biotechnology Corporation ,Swallows Head Neck Cancer Support Group ,Neck Cancer Awareness Month ,Neck Cancer Awareness Week ,Neck Cancer Support Group ,Executive Director ,Neck Cancer ,Clinical Oncology ,Annual Meeting ,Fast Track ,United States Securities Exchange Act ,United States Securities Act ,Cancer Institute ,Related Head ,Clinical Medicine ,Pds Biotechnology Corporation Stock Exchange ,News ,Information ,Press Release ,Florham ,Pril ,023 ,Ads ,Biotechnology ,Corporation ,Immunotherapy ,Company ,Developing ,Rowing ,Pipeline ,F ,Argeted ,Mmunotherapies ,Or ,Dancer ,Nd Pdsb Us70465t1079 ,